In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 5, 2006, Pages 643-649

  Pellegatta, Fabio ^a,b   Catapano, Alberico Luigi ^a   Luzi, Livio ^c   Terruzzi, Ileana ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Faculty of Exercise Sciences   (Italy)

Author keywords

Akt; Amino acids; Endothelium; ERK; Insulin; PI 3K

Indexed keywords

AMINO ACID; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DOWNSTREAM PROCESSING; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

AMINO ACIDS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 33748145104     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211751.01326.fa     Document Type: Article

References (36)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419-S420.
2. Dandona P, Aljada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am J Cardiol. 2002;90:27G-33G.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
4. Bar RS, Boes M, Dake BL, et al. Insulin, insulin-like growth factors, and vascular endothelium. Am J Med. 1998;85:59-70.
5. Baumgartner-Parzer SM, Waldhausl WK. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp Clin Endocrinol Diabetes. 2001;2:S166-S179.
6. Montagnani M, Quon MJ. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab. 2000;2:285-292.
7. Meijer AJ, Sauerwein HP. Amino acid-dependent signal transduction and insulin sensitivity. Curr Opinion Clin Nutr Metab Care. 1999;2:207-211.
8. Hara K, Yonezawa K, Weng QP, et al. Amino acid sufficiency and mTor regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem. 1998;273:14484-14494.
9. Rhoads RE. Signal transduction pathways that regulate eukaryotic protein syntesis. J Biol Chem. 1999;274:30337-30340.
10. Terruzzi I, Pellegatta F, Luzi L. Differential p70S6k and 4E-BP1 regulation by insulin and amino acids in vascular endothelial and smooth muscle cells. Acta Diabetol. 2005;42:139-146.
11. Dupont J, LeRoith D. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res. 2001;55:22-26.
12. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
13. Jcnsen CJ, Buch MB, Krag TO, et al. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J Biol Chem. 1999;274:27168-27176.
14. Nave BT, Owwens M, Withers DJ, et al. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J. 1999;344:427-431.
15. Lijima Y, Laser M, Shiraishi H, et al. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J Biol Chem. 2002;277:23065-23075.
16. Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci. 2001;114:2903-2910.
17. Hermann C, Assmus B, Urbich C, et al. Insulin-mediated stimulation of protein kinase AKT: a potent survival signaling cascade for endothelial cells. Arterioscl Thromb Vasc Biol. 2000;20:402-409.
18. Montagnani M, Chen H, Barr VA, et al. Insulin-stimulated activation of eNOS is independent of Ca2+ requires phosphorylation by Akt at Ser(1179). J Biol Chem. 2001;276:30392-30398.
19. Meijer AJ. Amino acids as regulators and components of non proteinogenic pathways. J Nutr. 2003;133:2057S-2062S.
20. Vinals F, Chambard JC, Pouyssegur J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem. 1999;274:26776-26782.
21. Tremblay F, Marette A. Amino acids and insulin signaling via the mTor/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem. 2001;276:38052-38060.
22. Greiwc JS, Kwon G, MeDaniel ML, et al. Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab. 2001;281:E466-E471.
23. Patti ME, Brambilla E, Luzi L, et al. Bidirectional modulation of insulin action by amino acids. J Clin Invest. 1998;101:1519-1529.
24. Liboshi Y, Papst PJ, Kawasome H, et al. Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation. J Biol Chem. 1999;274:1092-1099.
25. Herbert TP, Tee AR, Proud CG. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J Biol Chem. 2002;277:11591-11596.
26. Cheatham B, Vlahos CJ, Cheatham L, et al. Phosphatidylinositol 3-kinase activation is requiered for insulin stimulation of pp70kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994;14:4902-4911.
27. Cross MJ, Stewart A, Hodgkin MN, et al. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem. 1995;270:25352-25355.
28. Vlahos CJ, Matter WF, Hui KY, et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-one (LY294002). J Biol Chem. 1994;269:5241-5248.
29. Toker A, Newton AC. Akt/protein kinase B is regulated by autophosphorylation at the hipotetical PDK-2 site. J Biol Chem. 2000;275:8271-8274.
30. Anderson KE, Coadwell J, Stephens LR, et al. Traslocation of PDK-1 to the plasma membrane is important in allowing pdk-1 to activate protein kinase B. Curr Biol. 1998;8:684-691.
31. Vanhaesebroeck B, Alessi D. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 2000;346:561-576.
32. Zierath JR, Wallberg-Henriksson H. From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients. Ann N Y Acad Sci. 2002;967:120-134.
33. Moelling K, Schad K, Bosse M, et al. Regulation of Raf-Akt crosstalk. J Biol Chem. 2002;277:1099-1106.
34. Standaert ML, Bandyopadhyay G, Perez L, et al. Insulin activates protein kinase C-ζand C-λ by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT 4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem. 1999;274:25308-25316.
35. Bandyopadhyay G, Standaert ML. Activation of protein kinjase C (α, β, and ζ) by insulin in 3T3/L1 cells. J Biol Chem. 1997;272:2551-2558.
36. Letiges M, Plomann M, Standaert ML, et al. Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol. 2002;16:847-858.